INTERNATIONAL PATENT: SAREPTA THERAPEUTICS, INC., HOFFMANN-LA ROCHE INC. FILES APPLICATION FOR "METHODS OF RISK ASSESSMENT FOR MUSCULAR DYSTROPHY GENE THERAPY"

GENEVA, Aug. 19 -- SAREPTA THERAPEUTICS, INC. (215 First StreetCambridge, Massachusetts 02142), HOFFMANN-LA ROCHE INC. (150 Clove RoadOverlook at Great Notch, Suite 8Little Falls, New Jersey 07424) filed a patent application (PCT/US2024/046972) for "METHODS OF RISK ASSESSMENT FOR MUSCULAR DYSTROPHY GENE THERAPY" on Sep 16, 2024. With publication no. WO/2025/170636, the details related to the patent application was published on Aug 14, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KHAN, Sohrab (c/o Sarepta Therapeutics, Inc.215 First StreetCambridge, Massachusetts 02142), RODINO-KLAPAC, Lou...